Reduced hypothermic effects of cholinomimetic agents following chronic anticholinesterase treatment.
D000818:Animals; D001066:Appetite / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects*; D001833:Body Temperature Regulation / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D007031:Hypothalamus / Q000201:enzymology; D007531:Isoflurophate / Q000494:pharmacology; D008297:Male; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors*; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D010862:Pilocarpine; D007531:Isoflurophate; D002217:Carbachol; D002802:Cholinesterases